Boryung to export new antihypertensive agent to Brazil
Published: 2012-10-09 06:56:00
Updated: 2012-10-09 06:56:00
Boryung Pharmaceutical Co. today said it has signed an exclusive distribution agreement with Brazil’s largest drugmaker Ache Pharmaceutical, who will take care of commercializing Boryung’s new antihypertensive drug Kanarb (fimasartan).
Under the agreement, Boryung will deliver Kanrb, worth $40...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
